Earnings Labs
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX)

NASDAQ·Healthcare·Medical - Devices

$101.50

-6.13%

Mkt Cap $3.81B

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Feb 24, 2026

$155.39M$160.76M+3.46%$0.41$0.57+39.02%
Q4 2025

Oct 29, 2025

$155.41M$143.82M-7.46%$0.37$0.66+78.38%
Q3 2025

Jul 30, 2025

$141.62M$157.37M+11.12%$0.48$0.92+91.67%
Q2 2025

May 8, 2025

$123.39M$143.54M+16.32%$0.29$0.70+141.38%
Q1 2025

Feb 27, 2025

$109.49M$121.62M+11.08%$0.22$0.19-13.64%
Q4 2024

Oct 28, 2024

$112.18M$108.76M-3.04%$0.29$0.12-58.62%
Q3 2024

Jul 31, 2024

$114.13M$114.31M+0.15%$0.21$0.35+66.67%
Q2 2024

Apr 30, 2024

$83.90M$96.85M+15.44%$0.03$0.35+974.94%
Q1 2024

Feb 26, 2024

$68.51M$81.17M+18.48%$0.02$0.12+500.00%
Q4 2023

Nov 6, 2023

$49.19M$66.43M+35.05%-$0.18-$0.12+33.33%
Q3 2023

Aug 3, 2023

$42.42M$52.47M+23.68%-$0.15-$0.03+80.00%
Q2 2023

May 1, 2023

$36.05M$41.55M+15.27%-$0.25-$0.08+68.00%
Q1 2023

Feb 22, 2023

$24.45M$31.38M+28.34%-$0.28-$0.21+25.00%
Q4 2022

Nov 3, 2022

$18.88M$25.68M+36.07%-$0.40-$0.25+37.50%
Q3 2022

Aug 1, 2022

$16.27M$20.52M+26.09%-$0.32-$0.41-28.12%
Q2 2022

May 3, 2022

$9.66M$15.88M+64.37%-$0.35-$0.38-8.57%
Q1 2022

Feb 23, 2022

$7.51M$9.67M+28.69%-$0.43-$0.46-6.98%
Q4 2021

Nov 9, 2021

$8.12M$5.37M-33.87%-$0.32-$0.47-46.87%
Q3 2021

Aug 5, 2021

$7.55M$8.17M+8.23%-$0.27-$0.39-44.44%
Q2 2021

May 4, 2021

$7.05M$7.05M+0.00%-$0.28-$0.29-3.57%